How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study

Purpose Parenteral morphine is widely used for dyspnea of imminently dying cancer patients, but the outcomes to expect over time remain largely unknown. We examined outcomes after the administration of parenteral morphine infusion over 48 h in cancer patients with a poor performance status.